1.6 — Meetings
Meeting requests and minutes for pre-IND, pre-NDA/BLA, and Type A/B/C meetings
Requirements by Phase
Meeting requests and minutes for pre-IND, pre-NDA/BLA, and Type A/B/C meetings
Requirements by Phase
IND Phase 1: optional IND Phase 2: optional IND Phase 3: optional NDA: required
Content Requirements
- Pre-IND meeting requests with proposed agenda and questions
- Pre-NDA/BLA meeting requests
- Type A meeting requests (critical path issues, dispute resolution)
- Type B meeting requests (pre-IND, pre-NDA, mid-cycle)
- Type C meeting requests (other meetings)
- Briefing documents with background, data summaries, and specific questions
- Meeting minutes and agreed-upon action items
Expected Deliverables
- Meeting request letter
- Briefing document
- Meeting minutes
ICH Guidelines: FDA Guidance on Formal Meetings Between FDA and Sponsors
Source: FDA Formal Meetings Guidance
References
Sections
Related Sections
Up toModule 1: Administrative Information and Prescribing InformationComplete table of contents for the submission
Cover letter identifying the IND submission type, serial number, and key information
Administrative information including contact details, certifications, and financial disclosures
Letters of authorization, right of reference statements, and cross-references to other applications
Application status requests including withdrawal, inactivation, and reactivation
+6 more sections
Check your compliance against this section
Upload your study data and get instant gap analysis with specific regulatory citations.
Try Compliance Check